EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial

Jens Trøan iD, Evald Høj Christiansen, Kirstine Nørregaard Hansen, Ashkan Eftekhari, Lars Jakobsen, Michael Mæng, Phillip Freeman, Rebekka Vibjerg Jensen, Martin Kirk Christensen, Manijeh Noori, Julia Ellert-Gregersen, Nicolaj Brejnholt Støttrup und 3 weitere

Diabetes and Vascular Disease Research · 2024

DOI: 10.1177/14791641241283939 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes and Vascular Disease Research, 2024. Verfasst von Jens Trøan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Sirolimus, Percutaneous Coronary Intervention, Absorbable Implants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Biotronik, Terumo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes mellitus is associated with higher risk of target lesion failure (TLF) after percutaneous coronary intervention. We studied the 5-year outcome in patients with diabetes mellitus treated with biodegradable polymer stents.

Methods

The SORT OUT VII was a randomised trial comparing the ultrathin sirolimus-eluting Orsiro stent (O-SES) and the biolimus-eluting Nobori stent (N-BES) in an all-comer setting. Patients ( n = 2525) were randomised to receive O-SES ( n = 1261, diabetes: n = 236) or N-BES ( n = 1264, diabetes: n = 235). Endpoints were TLF (a composite of cardiac death, target-lesion myocardial infarction (MI), target lesion revascularization (TLR)), definite stent thrombosis and a patient related outcome (all-cause mortality, MI and revascularization) within 5 years.

Results

Patients with diabetes mellitus had higher TLF (20.6% vs 11.0%, (Rate ratio (RR) 1.85 95% confidence interval (CI): (1.42-2.40) and patient related outcome (42.0% vs 31.0%, RR 1.43 95% CI: (1.19-1.71)) compared to patients without diabetes. Among patients with diabetes mellitus, TLF after 5 years did not differ between O-SES and N-BES (21.2% vs 20.0%), RR 1.05 95% CI: (0.70-1.58), p = 0.81). Cardiac death, MI, TLR, and definite stent thrombosis did not differ between the groups.

Conclusion

In patients with diabetes mellitus, 5-year outcomes were similar among patients treated with biodegradable polymer O-SES or N-BES. Clinical trial registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT01879358.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsSirolimusPercutaneous Coronary InterventionAbsorbable ImplantsCoronary Artery DiseaseProsthesis DesignCardiovascular AgentsDiabetes MellitusHumansMaleFemaleMiddle AgedAgedTreatment OutcomeTime FactorsRisk FactorsPolymersCoronary ThrombosisMyocardial Infarction

Stichwörter der Autor:innen

Drug-eluting stentbiodegradable polymerdiabetes mellitustarget lesion failure

Substanzen

SirolimusumirolimusCardiovascular AgentsPolymers

Autor:innen und Institutionen

  • Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.

ORCID-Profile: Jens Trøan

Förderung

  • Biotronik
  • Terumo

Zitieren

APA

Trøan, J., Christiansen, E. H., Hansen, K. N., Eftekhari, A., Jakobsen, L., Mæng, M., Freeman, P., Jensen, R. V., Christensen, M. K., Noori, M., Ellert-Gregersen, J., Støttrup, N. B., Kahlert, J., Veien, K. T., & Jensen, L. O. (2024). Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial. Diabetes and Vascular Disease Research. https://doi.org/10.1177/14791641241283939

Vancouver

Trøan J, Christiansen EH, Hansen KN, Eftekhari A, Jakobsen L, Mæng M, et al. Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial. Diabetes and Vascular Disease Research. 2024. doi:10.1177/14791641241283939

BibTeX
@article{Tran2024,
  author = {Trøan, Jens and Christiansen, Evald Høj and Hansen, Kirstine Nørregaard and Eftekhari, Ashkan and Jakobsen, Lars and Mæng, Michael and Freeman, Phillip and Jensen, Rebekka Vibjerg and Christensen, Martin Kirk and Noori, Manijeh and Ellert-Gregersen, Julia and Støttrup, Nicolaj Brejnholt and Kahlert, Johnny and Veien, Karsten Tange and Jensen, Lisette Okkels},
  title = {Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial},
  journal = {Diabetes and Vascular Disease Research},
  year = {2024},
  doi = {10.1177/14791641241283939}
}
Kostenlos starten →